Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» erenumab
erenumab
Amgen pulls ahead in sprint towards CGRP approval with promising PhIII migraine data
Endpoints
Wed, 11/29/17 - 09:44 pm
Amgen
CGRP blockers
migraines
Aimovig
erenumab
[forum discussion]New neuro sales force for Amgen migraine drug erenumab
Cafepharma Message Boards
Tue, 10/17/17 - 12:40 pm
Amgen
drug reps
hirings
migraines
erenumab
Amgen And Novartis: First Mover Advantage Is A Must
Seeking Alpha
Mon, 07/24/17 - 11:55 pm
Amgen
Novartis
migraines
erenumab
CGRP blockers
Analysts offer a lukewarm endorsement to Amgen for PhIII migraine data; Arsanis raises $45.5M Series D; Covance faces restructuring
Endpoints
Wed, 04/26/17 - 11:29 am
migraines
Amgen
Covance
erenumab
With late-stage data in on the CGRP migraine drug erenumab, Novartis and Amgen rework commercialization pact
Endpoints
Tue, 04/25/17 - 11:03 am
Novartis
Amgen
CGRP blockers
migraines
erenumab
Amgen eyes spending caps to win payer nods on migraine prospect erenumab
Fierce Pharma
Mon, 11/21/16 - 11:31 am
Amgen
migraines
payers
erenumab
Amgen's migraine drug succeeds in late-stage trial
Yahoo/Reuters
Wed, 11/16/16 - 09:52 pm
Amgen
migraines
erenumab
Amgen Maintains Migraine Drug Lead (AMGN)
Investopedia
Fri, 09/30/16 - 10:05 am
Amgen
migraines
erenumab
Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field
Endpoints
Thu, 09/29/16 - 08:23 am
Novartis
Amgen
CGRP blockers
migraines
erenumab